THERAPEUTIC AGENT FOR CEREBRAL ISCHEMIC INJURY
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 23, 2010
app pub date -
Dec 25, 2008
filing date -
Dec 26, 2007
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
A therapeutic agent for cerebral ischemic injury contains at least one selected from L-alanyl-L-histidine and glycyl-L-histidine as an active ingredient. The therapeutic agent for cerebral ischemic injury preferably has a dosage form as an injection for intravenous administration. The therapeutic agent for cerebral ischemic injury having a dosage form as an aqueous injection contains at least one selected from L-alanyl-L-histidine and glycyl-L-histidine at a concentration of preferably 0.3 to 3.5 mol/L, and more preferably 0.6 to 2.1 mol/L.
First Claim
Other Claims data not available
Family
+
−
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| CN | A | CN101951935 | Dec 25, 2008 |
| EP | A1 | EP2228068 | Dec 25, 2008 |
| WO | A1 | WO2009081991 | Dec 25, 2008 |
| JP | B2 | JP5298028 | Dec 25, 2008 |
| TW | A | TW200938185 | Dec 26, 2008 |
International Classification(s)
- 2008 Application Filing Year
- A61K Class
- 9711 Applications Filed
- 5862 Patents Issued To-Date
- 60.37 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 2 Citation Count
- A61K Class
- 11.97 % this patent is cited more than
- 15 Age